Structural insights reveal how SPOP protein contributes to cancer

bySt. Jude Children's Research HospitalL to R: L to R: Brian O’Flynn, Ph.D., Matthew Cuneo, Ph.D., and Tanja Mittag, Ph.D. Credit: St. Jude Children's Research HospitalSPOP is the most m

Updated on: December 26,2023

Structural insights reveal how SPOP protein contributes to cancer

bySt. Jude Children's Research HospitalL to R: L to R: Brian O’Flynn, Ph.D., Matthew Cuneo, Ph.D., and Tanja Mittag, Ph.D. Credit: St. Jude Children's Research HospitalSPOP is the most m

Updated on:December 26,2023

Patient-derived Organoids: Revolutionizing Cancer Research and Treatment

Updated on: November 14,2024

Patient-derived Organoids: Revolutionizing Cancer Research and Treatment

Updated on:November 14,2024

Faster liquid biopsies could replace invasive tissue cancer detections

by Zeina Kayyali,Purdue UniversityCredit: CC0 Public DomainTests to determine if you have cancer can be frightening, uncomfortable and time-consuming. Now, Purdue University researchers have dev

Updated on: December 18,2023

Faster liquid biopsies could replace invasive tissue cancer detections

by Zeina Kayyali,Purdue UniversityCredit: CC0 Public DomainTests to determine if you have cancer can be frightening, uncomfortable and time-consuming. Now, Purdue University researchers have dev

Updated on:December 18,2023

Black women with breast cancer may have worse outcomes than peers despite similar genetic recurrence scores

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainNon-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had wors

Updated on: December 24,2023

Black women with breast cancer may have worse outcomes than peers despite similar genetic recurrence scores

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainNon-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had wors

Updated on:December 24,2023

BRCA Exchange aggregates data on thousands of BRCA variants to understand cancer risk

by National Cancer InstituteCredit: National Cancer InstituteA global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes is available to the public. The B

Updated on: March 30,2024

BRCA Exchange aggregates data on thousands of BRCA variants to understand cancer risk

by National Cancer InstituteCredit: National Cancer InstituteA global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes is available to the public. The B

Updated on:March 30,2024

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene

Updated on: March 22,2024

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene

Updated on:March 22,2024

Causes and Risk Factors of Non-Small Cell Lung Cancer

Causes and Risk Factors of Non-Small Cell Lung CancerByLynne Eldridge, MDUpdated on July 16, 2021Medically reviewed byDoru Paul, MDWhile the exact causes ofnon-small cell

Updated on: January 28,2024

Causes and Risk Factors of Non-Small Cell Lung Cancer

Causes and Risk Factors of Non-Small Cell Lung CancerByLynne Eldridge, MDUpdated on July 16, 2021Medically reviewed byDoru Paul, MDWhile the exact causes ofnon-small cell

Updated on:January 28,2024

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on: December 22,2023

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on:December 22,2023

Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

byUniversity of LiverpoolCredit: CC0 Public DomainTreating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery,

Updated on: January 04,2024

Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

byUniversity of LiverpoolCredit: CC0 Public DomainTreating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery,

Updated on:January 04,2024

Why early treatment of esophageal cancer is critical

by DeeDee Stiepan,Mayo ClinicCredit: Mayo Clinic News NetworkEsophageal cancer, which is cancer that occurs in the esophagus—a long, hollow tube that runs from your throat to your stomach—is on

Updated on: January 08,2024

Why early treatment of esophageal cancer is critical

by DeeDee Stiepan,Mayo ClinicCredit: Mayo Clinic News NetworkEsophageal cancer, which is cancer that occurs in the esophagus—a long, hollow tube that runs from your throat to your stomach—is on

Updated on:January 08,2024

New method for early detection of relapse in the blood cancer disease myelodysplastic syndrome

by Karolinska InstitutetCredit: CC0 Public DomainResearchers at the Department of Medicine, Huddinge (MedH), Magnus Tobiasson and Eva Hellström-Lindberg have, together with the Nordic MDS group,

Updated on: March 20,2024

New method for early detection of relapse in the blood cancer disease myelodysplastic syndrome

by Karolinska InstitutetCredit: CC0 Public DomainResearchers at the Department of Medicine, Huddinge (MedH), Magnus Tobiasson and Eva Hellström-Lindberg have, together with the Nordic MDS group,

Updated on:March 20,2024

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Updated on: July 17,2024

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Updated on:July 17,2024